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Functional Assessment of
Heart Failure Patients
Leonard A. Kaminsky, PhD*, Mary S. Tuttle, MS
INTRODUCTION
Heart failure (HF) is the condition characterized by
the inability of the heart to pump sufficient blood to
meet the demands of the body. It has been well es-
tablished that both the prevalence and incidence
of HF is increasing.1 There are 2 primary types of
HF, categorized by ejection fraction: Reduced
ejection fraction and preserved ejection fraction.2
Additionally, HF is commonly classified into stages
from mild to severe using a symptom-based scale
related to functional limitations.
One of the hallmark features of HF is exercise
intolerance, which is accompanied by symptoms
of fatigue and shortness of breath.3 As the disease
progresses, patients experience a downward spi-
ral as these symptoms typically result in reduced
physical activity, which leads to progressively
worsening exercise intolerance. Typically, patients
with HF are faced with what can be termed a func-
tional disability. Often, their reduced functional
abilities restrict or may even prevent them from
performing occupational tasks, which may result
in loss of work. Additionally, it is well known that
patients with HF experience impairment in the
ability to carry out activities of daily living and
suffer from reduced quality of life.
The objective of this paper was to provide an
overview of assessments of functional ability of
patients with HF. Two categories of assessment
are reviewed: Cardiovascular function and mus-
cular function. The review includes procedural
guidance on how to administer the assessments
and information related to the advantages and
disadvantages of each method. Because both
HF types (reduced ejection fraction and preserved
ejection fraction) are characterized by exercise
intolerance, the procedures can be used effec-
tively with either type of HF.
CARDIOVASCULAR FUNCTION
The gold standard method for assessing cardio-
vascular functional capacity is measurement of
oxygen consumption (VO2) during a maximal ex-
ercise test. This procedure is known as cardio-
pulmonary exercise testing (CPX). The principle
outcome variable is maximal or peak oxygen VO2
(VO2max or VO2peak). Weber and colleagues
4 estab-
lished a classification system based on peak VO2
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KEY POINTS
 The gold standard measurement of cardiovascular functional capacity is peak oxygen consumption
obtained from a cardiopulmonary exercise test.
 The 6-minute walk test provides an indirect measure of cardiovascular functional capacity.
 Muscular functional capacity is assessed using either a 1-repetition maximum test of the upper and
lower body or other methods, such as handgrip measurement.
 The short physical performance battery may provide a helpful, indirect indication of muscular
functional capacity.
for patients with HF (Table 1). Although exercise
testing guidelines have existed for more than
40 years,5 there is not a uniformly accepted stan-
dard for assessing cardiovascular functional ca-
pacity in terms of VO2. Review of the scientific
and clinical literature reveals that both VO2max
and peak VO2 are routinely reported. As reviewed
by Arena and colleagues,6 historically VO2max is
used when the measurement methodology in-
cludes determination of a plateau in VO2 measure-
ment values during the last 2 work rates of the
exercise test. However, not all studies that report
the variable in terms of VO2max used that as a crite-
rion and this method is not typically suitable for
use with ramp-style protocols. Alternatively, peak
VO2 is used when the method determines the high-
est VO2 value, expressed as milliliters of oxygen
per kilogram of body weight per minute (mL
O2kg1min1) during the exercise test. Another
challenge in interpretation is that different studies
have used various measurement sampling inter-
vals to determine VO2. A recent scientific state-
ment from the American Heart Association
recommends using a rolling average of three 10-
s sampling intervals during the exercise test to
help standardize this important outcomemeasure-
ment.7 For the purposes of this paper, the term
peak VO2 is used to indicate cardiovascular func-
tional capacity for patients with HF.
As mentioned, guidelines for exercise testing
have been available for more than 40 years. How-
ever, in the past 10 years as the evidence base has
grown, establishing the clinical importance of CPX
measures, there have been a number of scientific
statements released.7–10 Although the focus of
this paper is on the assessment of cardiovascular
functional capacity, it is important to recognize
that CPX is clearly recognized as a valuable
component in the diagnosis and prognosis of HF
patients. Indeed, the joint report from the Euro-
pean Society of Cardiology/European Association
for Cardiovascular Prevention and Rehabilitation
and the American Heart Association provides a
stratification approach for diagnosis and prog-
nosis of patients with HF.9 The key CPX measure-
ments, all clearly defined in the report, included in
the stratification are the slope of minute ventilation
(VE) relative to carbon dioxide production (VCO2;
VE/VCO2 slope); peak VO2; exercise oscillatory
ventilation; and the change in the partial pressure
of carbon. The stratification also includes consid-
eration of the blood pressure and electrocardio-
graphic response during the exercise test, the
rate of decline in heart rate after 1 minute of recov-
ery and the reason for test termination.
Assessing Peak Oxygen Consumption from
Exercise Tests
Recent guidelines and scientific statements are
available that provide comprehensive recommen-
dations for procedures for clinical exercise testing.
A brief overview of some of the important meth-
odologic points is reviewed in this section for ob-
taining the gold standard assessment of peak VO2.
Exercise testing can be performed with various
exercise modes; however, the 2 most common
choices are cycle ergometers and treadmills. The
advantages and disadvantages to both modes of
testing are listed in Table 2. There are 2 types of
cycle ergometers; Mechanically braked and elec-
trically braked. Work rates on mechanically braked
cycle ergometers can be varied by both the rate of
pedaling and the resistance to pedaling. This re-
quires a fixed pedal rate of typically 50 or 60 rpm
to achieve the desired fixed work rate. Electrically
braked cycle ergometers are designed to auto-
matically change the resistance on the pedal as
the pedal rate varies to maintain a desired fixed
work rate.
Exercise tests are administered according to
specified protocols with multiple variations
possible. The duration of an exercise test should
require at least 6 minutes but no more than 15 mi-
nutes, with an ideal time of 10 minutes. The first
decision in selecting a protocol is between a fixed
incremental or ramp style. A fixed incremental pro-
tocol uses a specific work rate either in watts on a
cycle ergometer or by a combination of speed and
elevation on a treadmill for a set period of time
(stage) of 1, 2, or 3 minutes. One of the most desir-
able features of fixed incremental protocols is that
the VO2 of each stage can be estimated (standard
error of estimate [SEE]  7%) using equations
provided by the American College of Sports
Table 1
Classification of heart failure patients based on
functional status
Peak VO2
(mL O2kgL1minL1) Classification
>20 A. Normal
16–20 B. Mild to moderate
impairment
10–15.9 C. Moderate to severe
impairment
<10 D. Severe
impairment
Abbreviation: VO2, oxygen consumption.
Data from Weber KT, Janicki JS, Ward DM, et al. Mea-
surement and interpretation of maximal oxygen uptake
in patients with chronic cardiac or circulatory failure. J
Clin Monit 1987;3:31–7.
Medicine.5 There are many standardized incre-
mental treadmill protocols. The Bruce protocol
was commonly used in routine cardiac diagnostic
assessments; however, the relatively high first
work rate of approximately 5 metabolic equiva-
lents (METs; 1 MET 5 3.5 mL O2kg1min1)
and the large stage increments of 2 to 3 METs
makes it unsuitable for patients with HF. Preferred
options for this population are either the modified
Naughton or a modified Balke protocol. For cycle
testing, few standardized protocols exist because
the maximal watt level varies directly with the total
body weight (muscle mass) of the patient. Cer-
tainly, some clinics use a number of standardized
incremental protocol options for cycle testing to
achieve different expected maximal watt levels.
Alternatively, both standardized and individualized
ramp-style protocols can be used. Unfortunately,
there are no standardized ramp protocols suitable
for HF patients. Individualized ramp protocols can
be derived using software options with metabolic
systems, which require setting a starting and
maximal speed of walking (or fixed speed) and
an estimate of the functional capacity of the pa-
tient in METs. The software then generates the in-
crements in speed and elevation to obtain the
estimated MET level in a targeted test time (usually
10 minutes). A similar process is used for cycle
testing, setting a starting and expected watt level
and then computing the rate of increase in watts
to be obtained in a linear fashion over a 10-minute
period of time.
Determination of peak VO2 during a CPX re-
quires collecting ventilatory expired gases during
the test. The 3 primary variables measured during
the test are the total ventilation and the fractional
concentrations of expired oxygen and carbon
dioxide. As mentioned, additional CPX variables
can also be measured, which have prognostic
and diagnostic utility. CPX measurements require
specialized equipment and trained personnel,
which can be a limiting factor, because these re-
sources may not be readily available. However,
as more academic programs have developed for
training individuals to administer these tests and
the costs of the equipment are relatively fixed (ie,
the primary cost is the purchase of the equipment,
the costs per test are minimal) the opportunities for
obtaining a measured peak VO2 are growing.
The next best option for assessing cardiovascu-
lar functional capacity is from a maximal exercise
test, performed without ventilatory expired gas
measurements. This option is commonly available
in cardiology clinics and practices. These tests are
primarily performed for diagnostic purposes with
routine monitoring of the exercise electrocardio-
gram, along with blood pressure, heart rate, and
signs and symptoms. These tests also require
specifically trained personnel. Cardiovascular
functional capacity can be estimated from either
a prediction equation using maximal test time
with standardized protocols or from the maximal
work rate obtained during the test. With use of
any prediction equation, there is some degree of
error associated with the estimation. Prediction
equations using test time typically have reported
error ranges of approximately 3 to 5 mL
O2kg1min1. Estimations from maximal work
rate are derived using the American College of
Sports Medicine equations. However, it is impor-
tant to recognize that this creates some issues,
because these equations were developed for
steady-state submaximal work rates (not maxi-
mal). Thus, the estimates may result in greater er-
ror ranges than those reported for the submaximal
level (ie, more than 7%).
Table 2
Advantages and disadvantages of cycle and treadmill modes of exercise testing
Mode Advantages Disadvantages
Cycle Smaller, portable Less familiar activity for patients
Less expensive Leg fatigue may cause early termination
Ausculatory blood pressure measurement
is easier
Electrically braked ergometers are difficult
to calibrate
Electrocardiogram tracings have fewer
artifacts
Lack of standardized testing protocols
Treadmill Walking is a more common activity for
patients
Balance issues, risk of falling
Typically higher peak VO2 values are
achieved
Handrail use will impact prediction of
peak VO2
Work rates can be increased by elevation at a
fixed speed
Blood pressure and electrocardiogram
measures are more difficult
Abbreviation: VO2, oxygen consumption.
A third option for assessing cardiovascular func-
tional capacity is from a submaximal exercise test.
These procedures rely on having a reasonable
estimation of maximal heart rate, commonly esti-
mated using age. A heart rate to VO2 (predicted
from work rate) relationship is established at 2
submaximal levels and then a linear line is extrap-
olated to derive an estimated maximal value.
Advantages of submaximal testing are that it
requires less training from staff, takes less time,
and because the patient’s effort is submaximal
has lower associated risks. However, because
many patients with HF are prescribed b-blocker
medications,2 prediction of maximal heart rate is
compromised. Thus, this method may not be
viable for many patients with HF. A summary of
the advantages and disadvantages of 3 exercise
testing methods is provided in Table 3.
Assessing Cardiovascular Functional Capacity
Without Exercise Tests
Exercise testing has inherent limitations (expense
[equipment and personnel], time, and risks associ-
ated with maximal exercise effort); thus, it is not
feasible in all settings. However, because under-
standing an HF patient’s exercise intolerance is
important for guiding therapy, alternative methods
of assessing cardiovascular functional capacity
have been developed.
Field tests for estimating aerobic fitness were
originally used with apparently healthy populations
andmost often involved running 1.5 miles or 12mi-
nutes.5 Variations of this approach were explored
with clinical populations using fixed distance or
time while walking. More than 30 years ago, But-
land and colleagues11 reported that walking for
6 minutes may provide useful information in pa-
tient populations with functional limitations. Since
that time, the 6-minute walk test (6MWT) has
gained acceptance in the clinical community as a
feasible option to obtain an estimate of cardiovas-
cular functional capacity in disease-based popula-
tions known to experience exercise intolerance.
Although it is beyond the scope of this paper to
provide a thorough review of the clinical uses
and limitations of the 6MWT, it is important to
recognize that the 6MWT does not accurately pre-
dict peak VO2.
12 Some reports have suggested
that failure to achieve a certain distance, such as
300 m13 or 450 m,14 on the 6MWT has prognostic
value. Additionally, some have proposed that
measures other than total distance achieved,
such as total work performed15 or heart rate after
1 minute of recovery16 may provide useful informa-
tion from the 6MWT. However, there are no well-
accepted normative values available to interpret
6MWT results.
The 6MWT is considered simple in concept in
terms of the patient directions; however, there
are important methodologic requirements. These
are briefly reviewed here, with more detailed infor-
mation available in the guideline statement from
the American Thoracic Society (ATS).17 The first
consideration is the location. Ideally, this should
be in a semiprivate area free from distractions
and potential obstacles. In most clinical settings,
this can be done in a hallway that is at least 30 m
long. However, it should be mentioned that the
length and type (oval vs back-and-forth) may result
Table 3
Advantages and disadvantages of 3 exercise testing methods for assessing cardiovascular functional
capacity
Mode Advantages Disadvantages
Maximal CPX Gold standard method Expense of equipment
Same diagnostic measures from
maximal exercise test
Specialized training required for technicians
Additional measures have
prognostic value
Additional time required for results
processing
Maximal
without CPX
More widely available in clinical
settings
Prediction errors in estimating functional
capacity
Less expense (equipment and
personnel)
Important prognostic indicators not available
Submaximal Lower risk because test effort is
submaximal
Maximal heart rate predictions not accurate
for those on b-blockers
Less expense (equipment and
personnel)
Prediction errors in estimating functional
capacity
Abbreviation: CPX, cardiopulmonary exercise test.
in slight differences in performance. Attempts to
perform this test on a treadmill have not been
found to be successful.18
Although there are few pretest requirements for
the patient, it is important to provide a clear set of
instructions pertaining to the objective (walk as far
as possible), the requirement to walk, not jog, and
the ability to stop and rest if needed. The ATS
guidelines provide a brief script that can easily
be read before each test. During the test, the
amount and type of verbal encouragement should
be consistent, because this can influence test
performance.19 The ATS guidelines also provide
recommendations for standardizing the communi-
cation with the patient during the test.
One of the most important issues with 6MWT
administration is a learning effect. The ATS guide-
lines suggest that “a practice test is not needed in
most clinical settings”; however, the guidelines
acknowledged that test performance is improved
on a second trail. In clinical programs where the
6MWT will be used to influence therapeutic op-
tions and in research settings, the validity of the
measurement is paramount. Thus, having patients
perform at least 1 practice trial is important. Inter-
estingly, Hanson and colleagues20 reported that
6MWT distance continued to improve over 3 trials
(regardless if performed on the same day or over 3
different days) in patients in a cardiac rehabilitation
program. Similarly, Wu and colleagues21 found
improvement over 3 consecutive trials both at
baseline and after 2 months. In patients with
more severe exercise tolerance limitations, such
as advanced HF, it was shown that a repeated trial
did not result in improvement in 6MWT distance.22
Key methodologic considerations for the 6MWT
are listed in Box 1. The importance of using stan-
dardized procedures cannot be overemphasized.
Although the 6MWT is the most commonly used
nonexercise test indicator of cardiovascular func-
tional capacity, other assessments have been
studied. Some investigators have determined the
ability of a shuttle walk test (SWT) to evaluate
chronic disease patient populations.14,23,24 This
test requires patients towalk back and forth around
2markers on a 10-mcourse (each 10m5 1 shuttle)
at a pace dictated by audio signals recorded on a
cassette tape or CD. The speed is initially set at
0.5 m/s and increased by 0.17 m/s every minute.
The test is terminated when the patient cannot
complete a shuttle in the required time interval. As
with the 6MWT, it is recommended that only stan-
dardized comments (no encouragement) be pro-
vided and that the SWT is repeated at least twice
to account for a learning effect.
The major distinguishing characteristic between
the 6MWT and SWT is the incremental nature of
the SWT. Proponents of the SWT suggest this
should result in a greater level of effort, compared
with the self-pace nature of the 6MWT, and thus
provide a better indicator of cardiovascular func-
tional capacity. Although this test may have merit,
to date, the research evidence base is lacking to
recommend it be used in place of the 6MWT.
Finally, there have been other attempts to im-
prove on the limitations of the 6MWT by evaluating
shorter distances. Studies have investigated the
utility of a 100-m walk test in patients with pulmo-
nary disease,25 200-m fast walking in patients in
cardiac rehabilitation,26 and a 400-m walk test in
patients with HF.27 All of these tests showed
some utility in evaluating patient populations; how-
ever, additional research is needed before re-
commending their use as an assessment of
cardiovascular functional capacity.
MUSCULAR FUNCTION
One of the most frequent misconceptions of HF is
that the limitations are solely related to the heart.
Evidence has existed for some time that one
of significant factors associated with exercise
intolerance in patients with HF is skeletal muscle
deconditioning.28 Recent studies have identified
mechanisms underlying the weakness observed
in the skeletal muscles or patients with HF.29,30
Thus, is it now well accepted that functional as-
sessments of patients with HF should include
measures of muscular performance. In general,
tests of muscular performance are not as common
as cardiovascular function in healthy adult popula-
tions. Even less has been done with disease-
based populations to evaluate muscular function.
Box 1
Important methodologic considerations for the
6-minute walk test
Standardized location is needed; free from
distractions/obstacles; distance between turn
around point ofw30 m.
Clear, standardized instructions should be read
to the patient before each test.
Clear, standardized feedback should be given to
the patient during each test.
Although not required, assessments of heart
rate, blood pressure, and rating of perceived
exertion are desirable.
To eliminate a learning effect impacting test
results, a minimum of 2 trials should be per-
formed (either with a short rest period or on a
separate day).
Thus, the review of muscular function assess-
ments provided herein is primarily based on work
with healthy adults. However, the procedures for
assessing patients with HF would not vary signifi-
cantly, only the interpretation of the results.
The gold standard method to assess muscular
strength is the 1-repetition maximum test (1-RM).
The procedures for this assessment are described
in Box 2. The resistance for the lifting can be either
free weights or resistance exercise machines.
Although a 1-RM can be obtained from any weight
lifting exercise, the 2 most common lifts are the
bench press (for upper body strength) and the
leg press (for lower body strength). The American
College of Sports Medicine guidelines provide a
set of normative values derived from an adult
population that was free from chronic disease.5
Unfortunately, there are no definitive standards
for interpreting 1-RM performance in patients
with HF. One of the major issues with performing
1-RM assessments is the time requirement, espe-
cially if patients need to be familiarized with using
the free weights or machines. Other issues are the
need for specialized equipment and trained
personnel and the risks associated with maximal
effort.
A second option for performing muscular func-
tion assessments is to use a handgrip dynamom-
eter. This test has been used for many years as a
physical fitness measure in school-aged children.
It does require a handgrip dynamometer; however,
these devices are relatively inexpensive (<$400)
and are durable. The procedure is simple, only
requiring the patient to squeeze the handle of the
dynamometer as hard as they can for 3 seconds.
After a short rest, the test is repeated 2 more
times, with each hand being tested. Although
normative values specific for patients with HF do
not exist, large population standards are avail-
able.31 These tests are starting to be administered
in the HF population and seem to have some
merit.32,33
There are also indirect measures of muscular
strength that can be used as indicators of mus-
cular functional ability. The origins for many of
these evaluations came from work with geriatric
populations. The method that seems to be gaining
the most acceptance is the Short Physical Perfor-
mance Battery.34 This functional test includes as-
sessments of gait speed (4 m), strength (sit to
stand, repeated 5 times), and balance (standing
position). A composite score is formulated, with
higher scores indicating better functional ability.
A recent study reported that the Short Physical
Performance Battery was reduced in patients
with HF with preserved ejection fraction compared
with age-matched controls and also correlated
with total and leg lean mass.35
There are other assessments used in geriatric
populations that may have utility in assessing the
muscular performance of patients with HF. These
include both the instrumental activities of daily
living36 and the timed up and go test.37
Finally, there are some questionnaire-based
methods that have been used in the HF population.
Myers and colleagues38 evaluated the Duke Activ-
ity Status Index, the Kansas City Cardiomyopathy
Questionnaire, and the Veterans Specific Activity
Questionnaire. They compared these question-
naires with results from CPX and the 6MWT in a
group of patients with HF. Their findings revealed
that these different methods did not correlate well
with each other and concluded that they should
not be used as surrogate indicators of functional
status in this population.
SUMMARY
Functional assessments of patients with HF pro-
vide important clinical information. Cardiovascular
functional capacity measures have been utilized
for many years. The gold standard method is
measuring peak VO2 from a CPX, which has added
Box 2
Important methodologic considerations for the
1 repetition maximum
To eliminate a learning effect impacting test re-
sults, patient should be familiarized with the
equipment used for the assessment (ideally on
a separate day).
Clear instructions regarding proper breathing
(no breath holding) needs to be explained
before each test.
Awarm up ofw5 repetitions of eachmovement
(bench press or leg press) with no weight is
important.
Select a weight that is submaximal (estimated
to be w75% of the patient’s capacity) and
have the patient complete 1 repetition.
Based on feedback from the patient, select a
higher weight that should be able to be lifted
1 time and after a 3-minute rest period attempt
1 repetition. If successful, have the patient
attempt 1 more lift of the next highest weight
increment. If not successful, lower the weight
by 1 increment and have the patient attempt
to complete 1 repetition.
Because different muscle groups are involved,
both the chest press and leg press tests should
be able to be completed at the same testing
session.
value by providing measurements with prognostic
utility. Peak VO2 can also be estimated from diag-
nostic maximal exercise tests, commonly used in
cardiac care and from submaximal exercise tests.
Indirect indicators of cardiovascular functional ca-
pacity can also be obtained, the most common of
which is the 6MWT. When performed with stan-
dardizedprocedures, the 6MWTcanprovide useful
information when measurements of peak VO2 are
not available or are not feasible.
The importance of skeletal muscle as a limiting
factor for patients with HF is now well understood.
This has led to increased interest in evaluating
muscular functional capacity in patients with HF.
Efforts are beginning to utilize measures that
have been commonly applied to evaluate the
muscular fitness of adults, the most common of
which are the 1-RM and handgrip. Interpretation
of results with normative standards for patients
with HF with these 2 assessments is lacking at
this time. Work is also beginning to utilize indirect
indicators of muscular functional capacity that
have been established in geriatric populations.
The assessment that may have the most promise
for patients with HF is the Short Physical Per-
formance Battery.
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